Cited 27 times in
A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 신재일 | - |
dc.date.accessioned | 2024-01-03T01:10:00Z | - |
dc.date.available | 2024-01-03T01:10:00Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 0146-6615 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/197474 | - |
dc.description.abstract | Long-term sequelae conditions of COVID-19 at least 2-year following SARS-CoV-2 infection are unclear and little is known about their prevalence, longitudinal trajectory, and potential risk factors. Therefore, we conducted a comprehensive meta-analysis of survivors' health-related consequences and sequelae at 2-year following SARS-CoV-2 infection. PubMed/MEDLINE, CENTRAL, and EMBASE were systematically searched up to February 10, 2023. A systematic review and meta-analysis were performed to calculate the pooled effect size, expressed as event rate (ER) with corresponding 95% confidence interval (CI) of each outcome. Twelve studies involving 1 289 044 participants from 11 countries were included. A total of 41.7% of COVID-19 survivors experienced at least one unresolved symptom and 14.1% were unable to return to work at 2-year after SARS-CoV-2 infection. The most frequent symptoms and investigated findings at 2-year after SARS-CoV-2 infection were fatigue (27.4%; 95% CI 17%-40.9%), sleep difficulties (25.1%; 95% CI 22.4%-27.9%), impaired diffusion capacity for carbon monoxide (24.6%; 95% CI 10.8%-46.9%), hair loss (10.2%; 95% CI 7.3%-14.2%), and dyspnea (10.1%; 95% CI 4.3%-21.9%). Individuals with severe infection suffered more from anxiety (OR = 1.69, 95% CI 1.17-2.44) and had more impairments in forced vital capacity (OR = 9.70, 95% CI 1.94-48.41), total lung capacity (OR = 3.51, 95% CI 1.77-6.99), and residual volume (OR = 3.35, 95% CI 1.85-6.07) after recovery. Existing evidence suggest that participants with a higher risk of long-term sequelae were older, mostly female, had pre-existing medical comorbidities, with more severe status, underwent corticosteroid therapy, and higher inflammation at acute infection. Our findings suggest that 2-year after recovery from SARS-CoV-2 infection, 41.7% of survivors still suffer from either neurological, physical, and psychological sequela. These findings indicate that there is an urgent need to preclude persistent or emerging long-term sequelae and provide intervention strategies to reduce the risk of long COVID. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Wiley-Liss | - |
dc.relation.isPartOf | JOURNAL OF MEDICAL VIROLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Anxiety / epidemiology | - |
dc.subject.MESH | COVID-19* / complications | - |
dc.subject.MESH | COVID-19* / epidemiology | - |
dc.subject.MESH | Carbon Monoxide | - |
dc.subject.MESH | Disease Progression | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Post-Acute COVID-19 Syndrome | - |
dc.subject.MESH | SARS-CoV-2 | - |
dc.title | A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학교실) | - |
dc.contributor.googleauthor | Masoud Rahmati | - |
dc.contributor.googleauthor | Raphael Udeh | - |
dc.contributor.googleauthor | Dong Keon Yon | - |
dc.contributor.googleauthor | Seung Won Lee | - |
dc.contributor.googleauthor | Xenia Dolja-Gore | - |
dc.contributor.googleauthor | Mark McEVoy | - |
dc.contributor.googleauthor | Tony Kenna | - |
dc.contributor.googleauthor | Louis Jacob | - |
dc.contributor.googleauthor | Guillermo F López Sánchez | - |
dc.contributor.googleauthor | Ai Koyanagi | - |
dc.contributor.googleauthor | Jae Il Shin | - |
dc.contributor.googleauthor | Lee Smith | - |
dc.identifier.doi | 10.1002/jmv.28852 | - |
dc.contributor.localId | A02142 | - |
dc.relation.journalcode | J01587 | - |
dc.identifier.eissn | 1096-9071 | - |
dc.identifier.pmid | 37288652 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/jmv.28852 | - |
dc.subject.keyword | COVID-19 | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.subject.keyword | long COVID | - |
dc.subject.keyword | meta-analysis | - |
dc.subject.keyword | prevalence | - |
dc.contributor.alternativeName | Shin, Jae Il | - |
dc.contributor.affiliatedAuthor | 신재일 | - |
dc.citation.volume | 95 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | e28852 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICAL VIROLOGY, Vol.95(6) : e28852, 2023-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.